$SABS 4 SEC Filings

Filed On	Filing
18 Sep 2026	Form 4: Kropotova Alexandra, CHIEF MEDICAL OFFICER Gave up 473 shares to cover exercise price or tax
26 Jun 2026	Form 4: Kropotova Alexandra, CHIEF MEDICAL OFFICER Gave up 988 shares to cover exercise price or tax
25 Mar 2026	Form 4: Kropotova Alexandra, CHIEF MEDICAL OFFICER Gave up 988 shares to cover exercise price or tax
05 Feb 2026	Form 4: Sullivan Eddie Joe, Director Granted 3,000,000 Stock option (right to buy)
05 Feb 2026	Form 4: Reich Samuel J, Director Granted 4,800,000 Stock option (right to buy)
05 Feb 2026	Form 4: Bausch Christoph Lawrence, CHIEF OPERATING OFFICER Granted 1,800,000 Stock option (right to buy)
05 Feb 2026	Form 4: Kropotova Alexandra, CHIEF MEDICAL OFFICER Granted 2,400,000 Stock option (right to buy)
05 Feb 2026	Form 4: To Lucy, See Remarks Granted 2,400,000 Stock option (right to buy)
07 Jan 2026	Form 4: Jain Rita, Director Granted 240,000 Stock Option (right to buy)
07 Jan 2026	Form 4: Zaccardelli David, Director Granted 240,000 Stock Option (right to buy)
18 Dec 2025	Form 4: Skyler Jay S, Director Granted 150,000 Stock Option (right to buy)
18 Dec 2025	Form 4: Polvino William James, Director Granted 150,000 Stock Option (right to buy)
18 Dec 2025	Form 4: Lucera Erick, Director Granted 150,000 Stock option (right to buy)
18 Dec 2025	Form 4: Ellias Helen K., Director Granted 150,000 Stock Option (right to buy)
18 Dec 2025	Form 4: Giberson Scott, Director Granted 150,000 Stock Option (right to buy)
18 Dec 2025	Form 4: Link David, Director Granted 150,000 Stock Option (right to buy)
12 Dec 2025	Form 4: Kropotova Alexandra, CHIEF MEDICAL OFFICER Gave up 988 shares to cover exercise price or tax
01 Oct 2025	Form 4: Moin Andrew, Director Received 1,740,000 shares by exercise or conversion ($3.05M)
01 Oct 2025	Form 4: Sessa Capital (Master), L.p., Director and 4 others Received 1,740,000 shares by exercise or conversion ($3.05M)
22 Sep 2025	Form 4: Kropotova Alexandra, CHIEF MEDICAL OFFICER Gave up 1,977 shares to cover exercise price or tax

Comments